Exact Mass: 374.0064714

Exact Mass Matches: 374.0064714

Found 85 metabolites which its exact mass value is equals to given mass value 374.0064714, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Deoxyribose triphosphate

C5H13O13P3 (373.9569038)

PHOSACETIM

Phosphoramidothioic acid, acetimidoyl-, O,O-bis(p-chlorophenyl) ester (8CI)

C14H13Cl2N2O2PS (373.9812388)

Tarzol

Fenazaflor

C15H7Cl2F3N2O2 (373.9836658)

6-Hydroxymethyletoricoxib

{5-[5-chloro-3-(4-methanesulfonylphenyl)pyridin-2-yl]pyridin-2-yl}methanol

C18H15ClN2O3S (374.0491870000001)

6-Hydroxymethyletoricoxib is only found in individuals that have used or taken Etoricoxib. 6-Hydroxymethyletoricoxib is a metabolite of Etoricoxib. 6-hydroxymethyletoricoxib belongs to the family of Bipyridines. These are organic compounds containing two pyridine rings linked to each other.

Etoricoxib 1'-N'-oxide

5-[5-chloro-3-(4-methanesulfonylphenyl)pyridin-2-yl]-2-methyl-1λ⁵-pyridin-1-one

C18H15ClN2O3S (374.0491870000001)

Etoricoxib 1-N-oxide is a metabolite of etoricoxib. Etoricoxib (brand name NUSHIN MASCOT HEALTH SERIES Arcoxia worldwide; also Algix and Tauxib in Italy, Nucoxia in India) is a COX-2 selective inhibitor (approx. 106.0 times more selective for COX-2 inhibition over COX-1) from Merck & Co. Currently it is approved in more than 70 countries worldwide but not in the US, where the Food and Drug Administration (FDA) requires additional safety and efficacy data for etoricoxib before it will issue approval. (Wikipedia)

Gavestinel

4,6-Dichloro-3-[2-(phenyl-C-hydroxycarbonimidoyl)eth-1-en-1-yl]-1H-indole-2-carboxylate

C18H12Cl2N2O3 (374.0224942)

Iodopindolol

1-[(3-iodo-1H-indol-4-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol

C14H19IN2O2 (374.0491224)

Sodium calcium edetate

calcium disodium 2-({2-[bis(carboxylatomethyl)amino]ethyl}(carboxylatomethyl)amino)acetate

C10H12CaN2Na2O8 (374.00149419999997)

Preservative and sequestrant in foods. Ethylenediaminetetraacetic acid, widely abbreviated as EDTA, is a polyamino carboxylic acid and a colourless, water-soluble solid. Its conjugate base is named ethylenediaminetetraacetate. It is widely used to dissolve limescale. Its usefulness arises because of its role as a hexadentate (six-toothed") ligand and chelating agent Preservative and sequestrant in foods

R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent D019141 - Respiratory System Agents > D005100 - Expectorants Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 1173

CHEBI:167831

C16H14ClF3N2OS (374.046742)

(1(15)E,2Z,4S,8R,9S)-8,15-dibromochamagra-1(15),2,11(12)-trien-9-ol|(1(15)E,2Z,4S,8R,9S)-8,15-dibromochamigra-1(15),2,11(12)-trien-9-ol|<1(15)E,2Z,4S,8R,9S>-8,15-dibromochamagra-1(15),2,11(12)-trien-9-ol

(1(15)E,2Z,4S,8R,9S)-8,15-dibromochamagra-1(15),2,11(12)-trien-9-ol|(1(15)E,2Z,4S,8R,9S)-8,15-dibromochamigra-1(15),2,11(12)-trien-9-ol|<1(15)E,2Z,4S,8R,9S>-8,15-dibromochamagra-1(15),2,11(12)-trien-9-ol

C15H20Br2O (373.98807899999997)

Austocystin G

C18H11ClO7 (374.0193286)

α,4-Dihydroxytriazolam

C17H12Cl2N4O2 (374.0337272)

6-Hydroxymethyletoricoxib

{5-[5-chloro-3-(4-methanesulfonylphenyl)pyridin-2-yl]pyridin-2-yl}methanol

C18H15ClN2O3S (374.0491870000001)

4-amino-n-[2-[(2-sulfoxy)ethyl]-sulfonyl]ethyl benzamide,sodium

C11H15N2NaO7S2 (374.02183599999995)

1,1,1,3,11,12-hexachlorododecane

C12H20Cl6 (373.96961000000005)

1,1,1,7,7,7-hexafluoro-2,6-bis(trifluoromethyl)hept-3-ene-2,6-diol

C9H6F12O2 (374.017616)

bis(n-propylcyclopentadienyl)zirconium dichloride

C16H22Cl2Zr (374.0145552)

Bis(1-ethyl-3-methylcyclopentadienyl)zirconium dichloride

C16H22Cl2Zr (374.0145552)

Bis(1-ethyl-2-methylcyclopentadienyl)zirconium dichloride

C16H22Cl2Zr (374.0145552)

Pyrroloquinolinequinone disodium salt

C14H4N2Na2O8 (373.9763064)

Pyrroloquinoline quinone disodium salt, a redox co-factor, is an anionic, redox-cycling orthoquinone. Pyrroloquinoline quinone disodium salt is isolated from cultures of methylotropic bacteria and tissues of mammals. Pyrroloquinoline quinone disodium salt is an essential nutrient for mammals and is important for immune function[1][2].

Bis[(2-guanidino-4-thiazolyl)methyl]disulfide

C10H14N8S4 (374.0224244)

zinc(II) 4-methylbenzenesulfinate

C14H14O4S2Zn (373.9624934)

LEAD MALEATE

C4H6O7Pb (373.9879936)

acetic acid,4-bromo-6-(2-phenyl-1H-pyrazol-3-ylidene)cyclohexa-2,4-dien-1-one

C17H15BrN2O3 (374.02659800000004)

(1S,2S)-1,2-Bis(4-nitrophenyl)-1,2-ethanediamine dihydrochloride

C14H16Cl2N4O4 (374.0548556)

1-butyl-3-methylimidazolium hexafluoroan

C8H15F6N2Sb (374.0177602)

3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanamide monohydrochloride

C8H15ClN6O3S3 (374.00562700000006)

triammonium iron(3+) trioxalate

C6H12FeN3O12 (373.97703620000004)

Edetate calcium disodium

Calcium disodium edetate dihydrate

C10H12CaN2Na2O8 (374.00149419999997)

D064449 - Sequestering Agents > D002614 - Chelating Agents > D065096 - Calcium Chelating Agents D000074385 - Food Ingredients > D005503 - Food Additives D006401 - Hematologic Agents > D000925 - Anticoagulants

Magnesium Ascorbate

(+)-Magnesium L-ascorbate

C12H14MgO12 (374.0335744)

D020011 - Protective Agents > D000975 - Antioxidants D018977 - Micronutrients > D014815 - Vitamins

Benzenesulfonamide,4-amino-N-(4-iodophenyl)-

C12H11IN2O2S (373.9585976)

gold (iii) acetate

C6H9AuO6 (374.0064714)

4-chloro-1-tosyl-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine

C15H10ClF3N2O2S (374.0103586)

2-[2-[(3-Aminobenzoyl)amino]ethylsulfonyl]ethyl hydrogen sulfate

C11H15N2NaO7S2 (374.02183599999995)

Ferric ammonium oxalate

C6H12FeN3O12 (373.97703620000004)

ethyl 2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptanoate

C9H6F12O2 (374.017616)

(5-Bromo-2-methylphenyl)[5-(4-fluorophenyl)-2-thienyl]methanone

C18H12BrFOS (373.9776214)

ethene,3,3,4,4,5,5,6,6,6-nonafluorohex-1-ene,1,1,2,2-tetrafluoroethene

C10H7F13 (374.03401379999997)

Etoricoxib N1-Oxide

C18H15ClN2O3S (374.0491870000001)

ethylenebis(1-indenyl)titanium(iv) dichloride

C20H16Cl2Ti (374.0108466)

Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methylene]amino]-, trans-

C13H16Br2N2O (373.9629286)

2,4-Bis(phenylsulfonyl)phenol

C18H14O5S2 (374.0282634)

Acetic acid, trifluoro-, boron complex

C6HBF9NaO6 (373.9620184)

ammonium tungstate pentahydrate, 99.

H18N2O9W (374.0521788)

Bromhexine Impurity F

C14H20Br2N2 (373.999312)

ammonium tungstate pentahydrate

H18N2O9W (374.0521788)

(1R,2R)-1,2-BIS(4-NITROPHENYL)ETHANE-1,2-DIAMINE DIHYDROCHLORIDE

C14H16Cl2N4O4 (374.0548556)

Bis(norbornadiene)rhodium(I) tetrafluoroborate

C14H16BF4Rh (374.0336144)

ethyl 5-iodo-2-(4-methylpiperazin-1-yl)benzoate

C14H19IN2O2 (374.0491224)

4-(4-acetylpiperazin-1-yl)-3-iodobenzoic acid

C13H15IN2O3 (374.012739)

ethyl 3-iodo-4-(4-methylpiperazin-1-yl)benzoate

C14H19IN2O2 (374.0491224)

3-iodo-4-(4-propan-2-ylpiperazin-1-yl)benzoic acid

C14H19IN2O2 (374.0491224)

4-[(4-ethylpiperazin-1-yl)methyl]-3-iodobenzoic acid

C14H19IN2O2 (374.0491224)

methyl 3-iodo-4-[(3-methylpiperazin-1-yl)methyl]benzoate

C14H19IN2O2 (374.0491224)

N-(4-Chlorobenzyl)-N-Methylbenzene-1,4-Disulfonamide

C14H15ClN2O4S2 (374.016174)

Gavestinel

C18H12Cl2N2O3 (374.0224942)

D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D018377 - Neurotransmitter Agents > D018684 - Glycine Agents

3,,4-Dihydro-2-(3-methoxyphenyl)-2h-thieno-[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide

C13H14N2O5S3 (374.00648340000004)

Calcium disodium ethylenediaminetetraacetate

C10H12CaN2Na2O8 (374.00149419999997)

N-[2-[[3-chloro-5-(triluoromethyl)pyridin-2-yl]methylsulanyl]ethyl]benzamide

C16H14ClF3N2OS (374.046742)

ethyl (2Z)-5-phenyl-2-(1,1,1-trifluoro-3-methoxy-3-oxopropan-2-ylidene)-1,3-oxathiole-4-carboxylate

C16H13F3O5S (374.04357640000006)

4-Fluorobenzoic acid 4-[(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)thio]but-2-ynyl ester

C17H11FN2O3S2 (374.0195108)

N-[(5-bromo-8-hydroxy-7-quinolinyl)-(2-furanyl)methyl]propanamide

C17H15BrN2O3 (374.02659800000004)

3-(3-bromophenyl)-2-(4-fluorophenyl)-5,6,7,7a-tetrahydro-3H-pyrrolo[1,2-c]imidazol-1-one

C18H16BrFN2O (374.04299579999997)

1-[[2-(1,3-Benzothiazol-2-ylthio)-1-oxoethyl]amino]-3-phenylthiourea

C16H14N4OS3 (374.0329714)

2-(4-Chlorophenyl)-6-(phenacylthio)-2,3-dihydrothiopyran-4-one

C19H15ClO2S2 (374.020196)

N-hydroxy-2-(4-iodopyrazol-1-yl)-6-methylsulanylbenzenecarboximidamide

C11H11IN4OS (373.9698306)

Fenazaflor

C15H7Cl2F3N2O2 (373.9836658)

Fatostatin (hydrobromide)

C18H19BrN2S (374.0452234)

Fatostatin hydrobromide (125B11 hydrobromide), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin hydrobromide binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin hydrobromide decreases the transcription of lipogenic genes in cells. Fatostatin hydrobromide possesses antitumor properties, and lowers hyperglycemia in ob/ob mice[1][2].